BRCA1 inhibition of estrogen receptor signaling in transfected cells

Science

Volumn 284, Issue 5418, 1999, Pages 1354-1356

  Fan, S ^a   Wang, J A ^a   Yuan, R ^a   Ma, Y ^a   Meng, Q ^a   Erdos, M R ^c   Pestell, R G ^a   Yuan, Fang ^a   Auborn, K J ^a   Goldberg, I D ^a,b   Rosen, E M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; EXPRESSION VECTOR; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION TERMINATION;

BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CELL DIVISION; ENHANCER ELEMENTS (GENETICS); EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, BRCA1; GENES, REPORTER; HUMANS; LIGANDS; MALE; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033591295     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5418.1354     Document Type: Article

References (24)

1. Y. Miki et al., Science 266, 66 (1994).
2. D. Ford, D. F. Easton, D. T. Bishop, S. A. Narod, D. E. Goldgar, Lancet 343, 692 (1994); J. P. Streuwing et al., N. Engl. J. Med. 336, 1401 (1997).
3. D. Ford, D. F. Easton, D. T. Bishop, S. A. Narod, D. E. Goldgar, Lancet 343, 692 (1994); J. P. Streuwing et al., N. Engl. J. Med. 336, 1401 (1997).
4. A. N. Monteiro, A. August, N. Hanafusa, Proc. Natl. Acad. Sci. U.S.A. 93, 13595 (1996); M. S. Chapman and I. M. Verma, Nature 382, 678 (1996).
5. A. N. Monteiro, A. August, N. Hanafusa, Proc. Natl. Acad. Sci. U.S.A. 93, 13595 (1996); M. S. Chapman and I. M. Verma, Nature 382, 678 (1996).
6. Y. Chen et al., Cancer Res. 56, 3168 (1996).
7. R. Hakem et al., Cell 85, 1009 (1996); J. T. Holt et al., Nature Genet. 12, 298 (1996); K. Somasundaram et al., Nature 389, 187 (1997).
8. R. Hakem et al., Cell 85, 1009 (1996); J. T. Holt et al., Nature Genet. 12, 298 (1996); K. Somasundaram et al., Nature 389, 187 (1997).
9. R. Hakem et al., Cell 85, 1009 (1996); J. T. Holt et al., Nature Genet. 12, 298 (1996); K. Somasundaram et al., Nature 389, 187 (1997).
10. N. Shao, Y. L. Chai, E. Shyam, P. Reddy, V. M. Rao, Oncogens 13, 1 (1996).
11. S. Fan et al., ibid. 16, 3069 (1998).
12. R. Scully et al., Cell 90, 425 (1997); L. C. Gowen, A. V. Avrutskaya, A. M. Latour, B. H. Koller, S. A. Leadon, Science 281, 1009 (1998).
13. R. Scully et al., Cell 90, 425 (1997); L. C. Gowen, A. V. Avrutskaya, A. M. Latour, B. H. Koller, S. A. Leadon, Science 281, 1009 (1998).
14. A. T. Ferguson and N. E. Davidson, Crit. Rev. Oncog. 8, 29 (1997).
15. T. Perlmann and R. M. Evans, Cell 90, 391 (1997); B. S. Katzenellenbogen, Biol. Reprod. 54, 287 (1996).
16. T. Perlmann and R. M. Evans, Cell 90, 391 (1997); B. S. Katzenellenbogen, Biol. Reprod. 54, 287 (1996).
17. P. M. Henttu, E. Kalkhoven, M. G. Parker, Mol. Cell. Biol. 17, 1832 (1997).
18. J. V. Rajan, M. Wang, S. T. Marquis, L. A. Chodosh, Proc. Natl. Acad. Sci. U.S.A. 93, 3078 (1996); J. V. Rajan et al., Dev. Biol. 184, 385 (1997).
19. J. V. Rajan, M. Wang, S. T. Marquis, L. A. Chodosh, Proc. Natl. Acad. Sci. U.S.A. 93, 3078 (1996); J. V. Rajan et al., Dev. Biol. 184, 385 (1997).
20. The wild-type BRCA1 expression plasmid (wtBRCA1) was created by cloning the BRCA1 cDNA into the pcDNA3 vector (Invitrogen) with artificially engineered 5′ Hin dIII and 3′ Not I sites. For transcription assays, we incubated asynchronously proliferating cells overnight at 50% to 70% of confluency in 24-well dishes with 0.5 μg of each vector (except where otherwise indicated) in serum-free Dulbecco's modified Eagle's medium (DMEM) containing Lipofectamine (Life Technologies). Cells were washed, incubated in serum-free phenolphthalein-free DMEM (0.2 ml per well) with or without 17β-estradiol (1 μM) for another 24 hours, and harvested for luciferase assays. Values are means ± SEM of four replicate wells and are representative of at least three experiments. Results were similar whether ER-α assays were performed in serum-free DMEM or in the presence of 2% charcoal-stripped serum.
21. G. Watanabe et al., Mol. Cell. Biol. 6, 3212 (1998).
22. V. R. Baichwal, A. Park, R. Tijan, Nature 352, 165 (1991); E. F. Flemington, S. H. Speck, W. G. Kaelin, Proc. Natl. Acad. Sci. U.S.A. 90, 6914 (1993).
23. V. R. Baichwal, A. Park, R. Tijan, Nature 352, 165 (1991); E. F. Flemington, S. H. Speck, W. G. Kaelin, Proc. Natl. Acad. Sci. U.S.A. 90, 6914 (1993).
24. Supported by U.S. Public Health Service (USPHS) grant R01-ES09169 (E.M.R.), the Elsa U. Pardee Cancer Foundation of Michigan (E.M.R.), the Susan G. Komen Breast Cancer Foundation (R.G.P.), and USPHS grant RO1-CA75503 (R.G.P.).